首都医科大学学报 ›› 2009, Vol. 30 ›› Issue (2): 218-221.

• 基础研究 • 上一篇    下一篇

胰岛素抵抗与非酒精性脂肪性肝病关系的实验研究

胡智阗, 车念聪, 夏蓉, 袁梦   

  1. 首都医科大学中医药学院
  • 收稿日期:2008-10-18 修回日期:1900-01-01 出版日期:2009-04-21 发布日期:2009-04-21
  • 通讯作者: 车念聪

Experimental Research of the Relationship between Insulin Resistance and Non-alcoholic Fatty Liver Disease

HU Zhi-tian, CHE Nian-cong, XIA Rong, YUAN Meng   

  1. School of Traditional Chinese Medicine, Capital Medical University
  • Received:2008-10-18 Revised:1900-01-01 Online:2009-04-21 Published:2009-04-21

摘要: 目的 探讨胰岛素抵抗(insulin resistance,IR)在非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)形成中的变化情况及两者间的关系。方法 复制非酒精性脂肪性肝病大鼠模型,将其分为2组,即模型组与药物组,模型组造模后不给任何处理,药物组用罗格列酮合二甲双胍干预治疗。检测大鼠造模第2、4、6、8周末的空腹胰岛素、空腹血糖,计算胰岛素抵抗指数和胰岛素敏感指数。结果 空腹血糖在各组间差异均无统计学意义。模型组和药物组在造模后第4周肝脏病理均检测提示形成NAFLD。模型组在造模后前两周没有出现明显的IR,从第4周末开始出现明显的持续外周IR状态;药物干预组在前4周无明显的IR,但第6周末和第8周末,出现了持续的IR。结论 IR可能并不是NAFLD发生的唯一启动因素,可能是NAFLD产生的一个结果;运用胰岛素增敏剂对肝脏病理的改善并不确切,不能阻止NAFLD疾病的发生,需要进行深入的临床和实验研究。

关键词: 非酒精性脂肪性肝病, 胰岛素抵抗

Abstract: Objective To observe the insulin resistance(IR) changes in non-alcoholic fatty liver disease(NAFLD), and to investigate the relationship between IR and NAFLD. Methods Experimental animal models of NAFLD were established, which were treated with insulin sensitizer-Metformin and Rosiglitazone. Fasting blood glucose and fasting insulin were tested by the end of the second week, fourth, sixth and eighth week. Insulin resistance index and insulin sensitivity index were calculated. Results There wasn't a significant difference between the fasting blood glucose of each group by the end of week four, NAFLD was formed in model group and treatment group. In the first two weeks, IR was not found in the model group. But by the end of the fourth week, sustained peripheral IR was found in this group. IR was not found in the treatment group in the first four weeks, but the results in the end of sixth week and eighth week showed that sustained IR was found in this group. Conclusion IR is not the (only) factor in forming NAFLD, maybe it is the result of NAFLD. The function of Insulin sensitizer is not reliable to pathological changes in liver, the drug can not prevent the formation of NAFLD. These results require further in-depth clinical and experimental research.

Key words: non-alcoholic fatty liver disease, insulin resistance

中图分类号: